Status:
COMPLETED
Effect of Enhanced External Counterpulsation
Lead Sponsor:
Chongming Hospital Affiliated to Shanghai University of Health & Medicine Sciences
Conditions:
Enhanced External Counterpulsation (EECP)
Acute Myocardial Infarction (AMI)
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This study evaluated the efficacy and safety of enhanced extracorporeal counterpulsation for cardiac rehabilitation in patients after DCB for acute myocardial infarction.
Eligibility Criteria
Inclusion
- patients with AMI diagnosed based on the universal definition of myocardial infarction criteria
- a single vessel infarcted, and Syntax score ≤22
- patients treated using DCB
- patients without EECP contraindications
- patients aged 18-75 years
- patients who had signed informed consent and were able to cooperate in completing the study
Exclusion
- patients with lower limb deep venous thrombosis and active thrombophlebitis
- patients with moderate to severe valvular heart disease, especially those with aortic insufficiency and/or stenosis
- patients with moderate to severe pulmonary arterial hypertension (mean pulmonary arterial pressure \>50 mmHg)
- patients with aortic, cerebral or dissecting aneurysms
- patients with uncontrolled hypertension (\>180/110 mmHg)
- patients with decompensated heart failure (cardiac function of grade IV)
- patients with arrhythmia that might interfere with the electrocardiographic gating function of the EECP device
- patients with haemorrhagic diseases or obvious bleeding tendencies
- patients with infected lesions in their limbs that may affect EECP
- pregnant women
- patients with ventricular aneurysm and mural thrombus detected through echocardiography
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06877390
Start Date
November 1 2023
End Date
April 30 2024
Last Update
March 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
P-ECP/TI EECP device
Shanghai, China